ライフサイエンスコーパス: communicable

1 Arab countries are now dealing with both non-communicable and infectious diseases.

2 could increase global deaths yearly from non-communicable and malnutrition-related diseases by 1.42 m

3 Social determinants are relevant to communicable and non-communicable disease alike.

4 4) to investigate trends in deaths caused by communicable and non-communicable diseases and injury.

5 seen in all age-groups and regions, although communicable and non-communicable diseases remained the

6 Worldwide, communicable and non-communicable diseases tend to segre

7 Mental disorders increase risk for communicable and non-communicable diseases, and contribu

8 health burden with risk factors that include communicable and non-communicable diseases.

9 h this increasingly prevalent dual burden of communicable and non-communicable diseases.

10 ns that can be integrated into management of communicable and non-communicable diseases.

11 umptions about the future rate of decline in communicable and non-communicable diseases.

12 and varies with inflammation rooted in both communicable and non-communicable diseases.

13 We review the communicable and non-communicable hazards that pilgrims

14 ng contributors to the burden of disease are communicable and perinatal disorders affecting children.

15 The dynamics, control, and evolution of communicable and vector-borne diseases are intimately co

16 istinctness metrics are effective yet easily communicable and versatile tools to assist objective glo

17 timated disease burdens of non-communicable, communicable, and malnutrition-related diseases with the

18 and nutritional disorders explain 43.9%; non-communicable causes 40.9%; injuries 15.1%; malignant neo

19 per 100,000 population by age and gender, by communicable (CD) and non-communicable disease (NCD) cau

20 e examined the behavioural correlates of non-communicable, chronic disease risk in low-income countri

21 o turn the tide of the growing burden of non-communicable, chronic, adult diseases that have their or

22 We estimated disease burdens of non-communicable, communicable, and malnutrition-related dis

23 With non-communicable conditions accounting for nearly two-thirds

24 odevelopmental impairment, stunting, and non-communicable conditions.

25 disease contributes substantially to the non-communicable disease (NCD) burden in low-income and midd

26 age and gender, by communicable (CD) and non-communicable disease (NCD) causes.

27 ession was used to analyse all-cause and non-communicable disease (NCD) mortality between 2006 and 20

28 minants are relevant to communicable and non-communicable disease alike.

29 veloping an understanding of the dynamics of communicable disease and assisting the construction and

30 The communicable disease and non-communicable disease sector

31 Since this transition, the prevention of non-communicable disease as well as communicable disease cau

32 ciation between socioeconomic status and non-communicable disease behavioural risk factors is well es

33 an ageing global population comes major non-communicable disease burden, especially in low-income an

34 Diphtheria is an acute, communicable disease caused by Corynebacterium diphtheri

35 ntion of non-communicable disease as well as communicable disease causes of adolescent mortality has

36 became the first chief epidemiologist at the Communicable Disease Center (CDC) in Atlanta, Georgia.

37 He was hired by the US Communicable Disease Center (now the Centers for Disease

38 When the Communicable Disease Center (now the Centers for Disease

39 I outline the Communicable Disease Center's first surveillance systems

40 The Communicable Disease Center, now the Centers for Disease

41 alth Service, which at the time included the Communicable Disease Center, the Centers for Disease Con

42 rganization was notified of an outbreak of a communicable disease characterized by fever, severe diar

43 ead of communicable diseases also challenges communicable disease control systems within the EU.

44 stems are to meet the emerging challenges to communicable disease control.

45 A raised baseline rate of communicable disease decline between 1990 and 2020 would

46 al Administrative Region, Harvard Center for Communicable Disease Dynamics from the National Institut

47 ramme and Wellcome Trust, Harvard Center for Communicable Disease Dynamics, and Health and Medical Re

48 e burden of morbidity and mortality from non-communicable disease has risen worldwide and is accelera

49 ctors that have contributed to the growth of communicable disease in Russia, Ukraine, and Belarus; se

50 obability of a man or woman dying from a non-communicable disease is higher in sub-Saharan Africa and

51 opment Goal (SDG) 3.4-reducing premature non-communicable disease mortality by a third by 2030-should

52 We projected that non-communicable disease mortality will increase from 28.1 m

53 Sequencing pathogen samples during a communicable disease outbreak is becoming an increasingl

54 rs, due to population ageing, changes in non-communicable disease rates, and increasing air pollution

55 Controlling an emerging communicable disease requires prompt adoption of measure

56 of diets associated with lower or higher non-communicable disease risk on the basis of multivariate m

57 The communicable disease and non-communicable disease sectors need to move beyond convent

58 In the 1960s and 1970s, communicable disease seemed a minor threat, but since th

59 ses has provoked a renewed focus on European communicable disease surveillance and control.

60 dated hospital discharge data unsuitable for communicable disease surveillance.

61 ed by a novel coronavirus (CoV), is a highly communicable disease with the lungs as the major patholo

62 al artery disease is a prevalent chronic non-communicable disease without obvious symptoms.

63 ies (around 50% of DALYs attributable to non-communicable disease), whereas China more closely resemb

64 ies (around 80% of DALYs attributable to non-communicable disease).

65 is study shows the reversal of HIV/AIDS, non-communicable disease, and injury mortality trends in Sou

66 side from HIV/AIDS, few CL episodes involved communicable disease, and none occurred in least-develop

67 hich has a growing prevalence of chronic non-communicable disease.

68 is little evidence that they are vectors of communicable disease.

69 here three-quarters of mortality is from non-communicable disease.

70 Tuberculosis is a major communicable disease.

71 Obesity is a common cause of non-communicable disease.

72 l to reduce rates of death from chronic (non-communicable) disease by an additional 2% every year.

73 entation of an effective response to the non-communicable-disease crisis will need political commitme

74 The threat of non-communicable diseases ("NCDs") is increasingly becoming

75 e richest 20% from a similar increase in non-communicable diseases (1.4 vs 5.3 years).

76 c health information in general (49 states), communicable diseases (42 states), and sexually transmit

77 den of Disease Study 2010, the burden of non-communicable diseases (cardiovascular disease, cancer, c

78 individuals towards risk of Diet Related Non-communicable Diseases (DR-NCDs).

79 uintile for HIV/AIDS and tuberculosis, other communicable diseases (excluding HIV/AIDS and tuberculos

80 hy eating guidelines that aim to prevent non-communicable diseases (increase fruits, vegetables, whol

81 e varied substantially by health topic, from communicable diseases (n=131), nutrition (n=77), to non-

82 e diseases (n=131), nutrition (n=77), to non-communicable diseases (n=8), and water, sanitation, and

83 Heightened risk of non-communicable diseases (NCD) in children exposed to SAM a

84 income countries, care for patients with non-communicable diseases (NCDs) and mental health condition

85 e premature mortality from the four main non-communicable diseases (NCDs) by 25% from 2010 levels by

86 approaches to prevention and control of non-communicable diseases (NCDs) have been elaborated in the

87 The burden of non-communicable diseases (NCDs) is disproportionately carri

88 Non-communicable diseases (NCDs) such as cardiovascular dise

89 unities have a higher risk of dying from non-communicable diseases (NCDs) than do more advantaged gro

90 xperiencing an increase in the burden of non-communicable diseases (NCDs), including cancer.

91 of 30 years and 70 years) from four main non-communicable diseases (NCDs)--cardiovascular diseases, c

92 le will increasingly develop age-related non-communicable diseases (NCDs).

93 vide an untapped opportunity to identify non-communicable diseases (NCDs).

94 deaths; a third of premature deaths from non-communicable diseases (NCDs); and a third of those from

95 n Plan for the Prevention and Control of Non-communicable Diseases 2013-2020, and in advancing the UN

96 millions of adults at increased risk of non-communicable diseases after low birthweight.

97 Transborder spread of communicable diseases also challenges communicable disea

98 tions age, and as progress continues against communicable diseases among infants and children.

99 the UN's political commitment to address non-communicable diseases and ensure universal access to dru

100 inued to shift away from communicable to non-communicable diseases and from premature death to years

101 l persist in LICs--whereas the burden of non-communicable diseases and injuries has increased.

102 n learnt about prevention and control of non-communicable diseases and injuries, which is well summar

103 ow confronting an increasing burden from non-communicable diseases and injuries.

104 almost half of expected disability is due to communicable diseases and injuries.

105 ceed the incremental gains in decreasing non-communicable diseases and injury burdens of high-income

106 ommunicable diseases narrowed over time, non-communicable diseases and injury burdens varied markedly

107 nds in deaths caused by communicable and non-communicable diseases and injury.

108 nificant global health burdens from both non-communicable diseases and micronutrient deficiencies.

109 rly 90% of expected disability is due to non-communicable diseases and most of the remainder to injur

110 ns, while at the same time, diet-related non-communicable diseases and obesity have exponentially inc

111 Urgent action is now required to control non-communicable diseases and reduce fatal injuries in Mexic

112 onal differences in the unfinished agenda of communicable diseases and reproductive, maternal, and ch

113 e solution is city planning that reduces non-communicable diseases and road trauma while also managin

114 of infections allows treatment of potential communicable diseases and updating of immunizations.

115 dult mortality risks from infections and non-communicable diseases are a result of historical childho

116 Non-communicable diseases are increasingly common causes of

117 poor, which population interventions for non-communicable diseases are most applicable in different c

118 Non-communicable diseases are the leading global cause of de

119 Non-communicable diseases are, however, already major public

120 itiative, a plan to cut mortality due to non-communicable diseases by 25% by 2025.

121 tobacco use and premature mortality from non-communicable diseases by a third by 2030.

122 re developed for key nutrients linked to non communicable diseases by an independent scientific commi

123 ct of physical inactivity on these major non-communicable diseases by estimating how much disease cou

124 ch about half the mortality reduction in non-communicable diseases called for by the Sustainable Deve

125 ing factual information about the dangers of communicable diseases can positively impact people's att

126 In 1990, communicable diseases caused 59% of death and disability

127 world's richest 20%, on the other hand, non-communicable diseases caused 85% of death and disability

128 The changing patterns of communicable diseases east of the EU's new border has im

129 isorders including diabetes, cardiovascular, communicable diseases etc.

130 rominently in the burgeoning epidemic of non-communicable diseases facing low- and middle-income coun

131 rders accounted for 17.2 million deaths, non-communicable diseases for 28.1 million deaths and injuri

132 illness (ILI) to the National Institute for Communicable Diseases for influenza testing by immunoflu

133 5) evaluation of personnel with exposure to communicable diseases for receipt of postexposure prophy

134 logical evidence, the policy response to non-communicable diseases has been weak.

135 High rates of non-communicable diseases have also been described with evid

136 wever, socioeconomic factors influencing non-communicable diseases have not been included in the plan

137 edictive values (PPVs) of ICD-9-CM codes for communicable diseases in 6 North Carolina health-care sy

138 e diseases in children towards those for non-communicable diseases in adults.

139 society by preventing and treating not only communicable diseases in all ages, but also noncommunica

140 Asthma-one of the most common chronic, non-communicable diseases in children and adults-is characte

141 stantially, with a shift away from risks for communicable diseases in children towards those for non-

142 han 3 million deaths per year, most from non-communicable diseases in low-income and middle-income co

143 Global and regional estimates show that non-communicable diseases in old age are rising in importanc

144 , care, and treatment, and management of non-communicable diseases in the poorest populations.

145 2008, with 446 annual excess deaths from non-communicable diseases in the UK (280 for young people ag

146 Mortality from non-communicable diseases in the UK fell from being roughly

147 has been among the most frequently reported communicable diseases in the United States since 1960.

148 ight the need to focus more attention on non-communicable diseases in this population and balance obe

149 nges of contact tracing for high-consequence communicable diseases included rapid comprehensive conta

150 Deaths from non-communicable diseases increased over time in both sexes,

151 As the prevalence of injuries and non-communicable diseases increases, the provision of effect

152 and diagnostic yield of integrating NCD and communicable diseases into a rapid HIV testing and refer

153 ty of integrating hypertension, diabetes and communicable diseases into HIV initiatives.

154 ntries in the Gulf region, the burden of non-communicable diseases is a major threat, primarily due t

155 and increasing burden of mortality from non-communicable diseases is likely to become prominent.

156 by mass drug administration programs against communicable diseases may necessitate increased vector c

157 Although state inequalities from communicable diseases narrowed over time, non-communicab

158 Cancer is one of the major non-communicable diseases posing a threat to world health.

159 Growing political recognition of non-communicable diseases provides a favourable political co

160 The rise in diabetes and other non-communicable diseases puts a heavy toll on health system

161 s and regions, although communicable and non-communicable diseases remained the main causes of death

162 Deaths from non-communicable diseases rose by just under 8 million betwe

163 cal guidelines for GAS pharyngitis and other communicable diseases should be considered for reducing

164 t in the global monitoring framework for non-communicable diseases should promote accountability for

165 Treatment of non-communicable diseases such as cancer in refugees is negl

166 verse health conditions, including major non-communicable diseases such as coronary heart disease, ty

167 f many pathologies, particularly chronic non-communicable diseases such as obesity and diabetes.

168 s, one can find regions having predominantly communicable diseases such as rheumatic heart disease, t

169 Worldwide, communicable and non-communicable diseases tend to segregate geographically.

170 We assess risks of communicable diseases that are associated with mass gath

171 coronary heart disease and other chronic non-communicable diseases that lower global life expectancie

172 nfancy and childhood as well as chronic, non-communicable diseases that may manifest at any point acr

173 e to worldwide epidemics of injuries and non-communicable diseases through traffic exposure, noise, a

174 DC from an agency focused almost entirely on communicable diseases to one engaged in a broad array of

175 f patient charts with ICD-9-CM diagnoses for communicable diseases were reviewed and evaluated for th

176 Substantial declines in death caused by communicable diseases were seen in all age-groups and re

177 n treatment, blood glucose level, having non-communicable diseases were significantly associated with

178 culosis remains one of the world's deadliest communicable diseases with 10 million incident cases and

179 herapies include commonly used drugs for non-communicable diseases with good safety profiles, immunom

180 As a result, a faster decline in communicable diseases would decease the poor-rich gap in

181 tal, and nutritional disorders, 43% from non-communicable diseases, and 10% from injuries.

182 alth security, antimicrobial resistance, non-communicable diseases, and climate change-but also the t

183 rders increase risk for communicable and non-communicable diseases, and contribute to unintentional a

184 (MDGs), addressing growing challenges of non-communicable diseases, and ensuring universal health cov

185 Mortality from tuberculosis, non-communicable diseases, and injuries decreased slightly.

186 rnal, perinatal, and nutritional causes, non-communicable diseases, and injury.

187 al budget to infectious diseases, 12% to non-communicable diseases, and less than 1% to injuries and

188 ogenic agents is likely to prevent other non-communicable diseases, and the cause could be removed or

189 vative assumptions for each of the major non-communicable diseases, by country, to estimate how much

190 Among chronic non-communicable diseases, cardiometabolic diseases and canc

191 However, amid Mexico's progress against communicable diseases, chronic kidney disease burden rap

192 child health, other infectious diseases, non-communicable diseases, Ebola, and sector-wide approaches

193 Development Goals and the challenges of non-communicable diseases, economic inequality, and climate

194 s early life factors in the aetiology of non-communicable diseases, including asthma/wheezing disorde

195 Non-communicable diseases, including cancer, are overtaking

196 The most common non-communicable diseases, including ischaemic heart disease

197 rly for infant deaths and mortality from non-communicable diseases, including neuropsychiatric disord

198 reflected in changes in the epidemiology of communicable diseases, including tuberculosis and HIV (i

199 everal risks that primarily affect childhood communicable diseases, including unimproved water and sa

200 ated at the international level, such as non-communicable diseases, mental health, and injuries.

201 action: malaria 8.0% and syphilis 7.7%), non-communicable diseases, nutrition and lifestyle factors (

202 he HIV epidemic, and increasing rates of non-communicable diseases, people in sub-Saharan Africa are

203 Despite mortality due to communicable diseases, poverty, and human conflicts, dem

204 focus areas (other infectious diseases, non-communicable diseases, sector-wide approaches, and other

205 Unlike most communicable diseases, the absolute burden and relative

206 transitions from diseases of poverty to non-communicable diseases, the burden of disease and health

207 n accelerated rate of overall decline in non-communicable diseases, the poor-rich gap would widen.

208 stablished U.S. guidelines for visitors with communicable diseases, thereby not limiting the rights o

209 The burden of non-communicable diseases, to which cancer contributes great

210 Among communicable diseases, tuberculosis is the second leadin

211 nd a third of those from other causes (other communicable diseases, undernutrition, and injuries).

212 Most increases in DALYs, especially from non-communicable diseases, were due to population growth.

213 ity on addressing the high prevalence of non-communicable diseases, with variations in policies betwe

214 DALYs from non-communicable diseases--especially ischaemic heart diseas

215 patterns are a global priority to reduce non-communicable diseases.

216 beginning to confront the rising tide of non-communicable diseases.

217 h preventing and controlling the rise of non-communicable diseases.

218 rtality, growth failure, and adult-onset non-communicable diseases.

219 in the context of the growing burden of non-communicable diseases.

220 s with expertise in control of infection and communicable diseases.

221 d help prevent such diet-related chronic non-communicable diseases.

222 sk factors that include communicable and non-communicable diseases.

223 val and reduce disability, stunting, and non-communicable diseases.

224 k of hormone-sensitive cancers and other non-communicable diseases.

225 tributor to adult obesity, diabetes, and non-communicable diseases.

226 and to address the emerging burden from non-communicable diseases.

227 neonatal, and nutritional causes towards non-communicable diseases.

228 revalent dual burden of communicable and non-communicable diseases.

229 as obesity, diabetes, and other chronic non-communicable diseases.

230 major modifiable risk factor for chronic non-communicable diseases.

231 ealth services, but poorly in addressing non-communicable diseases.

232 eg, US$1029.10 for HIV/AIDS to $3.21 for non-communicable diseases.

233 icant heterogeneities in the transmission of communicable diseases.

234 partly because of the overwhelming burden of communicable diseases.

235 ated into management of communicable and non-communicable diseases.

236 ere diabetes must compete for resources with communicable diseases.

237 and to establish syndromic surveillance for communicable diseases.

238 ture rate of decline in communicable and non-communicable diseases.

239 with no discernible funding targeted to non-communicable diseases.

240 the effective prevention and containment of communicable diseases.

241 rt of a comprehensive strategy to reduce non-communicable diseases.

242 ammation rooted in both communicable and non-communicable diseases.

243 ould be a risk of development of chronic non communicable diseases.

244 e no detailed assessments of late-onset, non-communicable diseases.

245 ological transition from communicable to non-communicable diseases.

246 annually through its effects on multiple non-communicable diseases.

247 National Institute for Communicable Diseases: Division of the National Health L

248 on precautions for patients with potentially communicable diseases; 4) proper use of personal protect

249 ns when caring for patients with potentially communicable diseases; and 5) evaluation of personnel wi

250 atal, and nutritional disorders; second, non-communicable diseases; and third, injuries.

251 iven to the issue of access to medicines for communicable diseases; however, access to essential medi

252 icable, nutritional, or maternal causes; non-communicable disorders; and injury.

253 CTs had significantly higher rates of acute communicable findings in all categories, except for acut

254 Acute communicable findings in at least one of four categories

255 The frequency of any acute communicable findings in neuroscience, medical, and surg

256 ion of altered mental status yields abnormal communicable findings.

257 In this issue, Garrett et al. describe a communicable form of colitis that is induced by deficien

258 REVIEW: Babesiosis is a zoonosis, a disease communicable from animals to humans and an important blo

259 the family Caliciviridae, and cause a highly communicable gastroenteritis in humans.

260 We review the communicable and non-communicable hazards that pilgrims face.

261 As with tuberculosis, STDs, and other communicable HIV-1-associated diseases, the net effect o

262 ent evidence, that periodontal pathogens are communicable; however, they are not readily transmissibl

263 ents and exposure of such patients to common communicable illnesses to which they may be inadvertentl

264 vely common but does not routinely result in communicable infections in the new host.

265 environment, and uncontrolled cancer-causing communicable infections.

266 ions means that many people with chronic non-communicable lung diseases are not given effective treat

267 Unlike many other non-communicable lung diseases, the proximal causes of many

268 Worldwide mortality from communicable maternal, perinatal, and nutritional disord

269 Communicable, maternal, neonatal, and nutritional causes

270 th rates combine to drive a broad shift from communicable, maternal, neonatal, and nutritional causes

271 At the most aggregate level, communicable, maternal, neonatal, and nutritional causes

272 Nevertheless, communicable, maternal, neonatal, and nutritional causes

273 In 1990, 47% of DALYs worldwide were from communicable, maternal, neonatal, and nutritional disord

274 In sub-Saharan Africa, however, many communicable, maternal, neonatal, and nutritional disord

275 distinguishes three broad categories: first, communicable, maternal, neonatal, and nutritional disord

276 decline in age-specific mortality rates from communicable, maternal, perinatal, and nutritional disor

277 Worldwide in 1990, communicable, maternal, perinatal, and nutritional disor

278 Communicable, maternal, perinatal, and nutritional disor

279 90, premature death and disability caused by communicable, newborn, nutritional, and maternal disorde

280 by Global Burden of Disease classification: communicable, nutritional, or maternal causes; non-commu

281 he analysis of nosocomial infection data for communicable pathogens is complicated by two facts.

282 Five of the ten leading killers are communicable, perinatal, and nutritional disorders large

283 5-49 years; 15% at ages 50-69 years; 30% for communicable, perinatal, maternal, or nutritional causes

284 Non-communicable respiratory diseases are an increasing prob

285 Non-communicable risk factors were the leading cause of DALY

286 Nod2 deficiency gives rise to a reversible, communicable risk of colitis and colitis-associated carc

287 language and develop explicit, symbolic, and communicable systems of knowledge that deliver rich repr

288 s to become colitogenic, and this colitis is communicable to genetically intact hosts.

289 ease burden has continued to shift away from communicable to non-communicable diseases and from prema

290 xamining the epidemiological transition from communicable to non-communicable diseases.

291 ate immune system results in spontaneous and communicable ulcerative colitis in the absence of adapti

292 Genotype-dependent disease risk was communicable via maternally transmitted microbiota in bo

293 Importance: Measles is a highly communicable viral infection with serious complications.